OrionMauriceHowardMD

PubMed

• Phase II study of neoadjuvant therapy with epirubicin and docetaxel for women with locally advanced breast cancer.
  Holter JL, Tfayli A, Venkattapa S, Bova A, Howard O> ;J. Clin. Oncol.. 2005-06-01
• 88 citations
  Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity.
  Ann S. LaCasce, Orion M. Howard, Shuli Li, David E. Fisher, Andrew P. Weng, Donna Neuberg, Margaret A. Shipp> ;Leukemia & Lymphoma. 2004 Apr 1
• 59 citations
  Seventy-Two Hour Continuous Infusion Flavopiridol in Relapsed and Refractory Mantle Cell Lymphoma
  Thomas S. Lin, Orion M. Howard, Donna Neuberg, Helen H. Kim, Margaret A. Shipp> ;Leukemia & Lymphoma. 2002 Apr 1
• 297 citations
  Rituximab and CHOP Induction Therapy for Newly Diagnosed Mantle-Cell Lymphoma: Molecular Complete Responses Are Not Predictive of Progression-Free Survival
  Orion M. Howard, John G. Gribben, Donna Neuberg, Michael L. Grossbard, Christina Poor, Milos J. Janicek, Margaret A. Shipp> ;Journal of Clinical Oncology. 2002 Mar 1
• 7 citations
  The cellular and molecular heterogeneity of the aggressive non-Hodgkin's lymphomas.
  Orion M. Howard, Margaret A. Shipp> ;Current Opinion in Oncology. 1998 Sep 1
• 15 citations
  Physician desire for euthanasia and assisted suicide: would physicians practice what they preach?
  Orion M. Howard, Diane L. Fairclough, Elisabeth R. Daniels, Ezekiel J. Emanuel> ;Journal of Clinical Oncology. 1997 Feb 1
• Join now to see all